Beckman Coulter Inc - Company Profile
Powered by 
All the data and insights you need on Beckman Coulter Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Beckman Coulter Inc Strategy Report
- Understand Beckman Coulter Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Beckman Coulter Inc (Beckman), a subsidiary of Danaher Corp, is a manufacturer of biomedical testing instrument systems. It develops, manufactures and markets biomedical laboratory instruments, software and other things that simplify and automate complex biomedical tests. Its comprehensive diagnostic tests, instruments and business management services help healthcare professionals in hospitals, laboratories and other critical care settings across the world to assess, diagnose and monitor conditions ranging from cardiac diseases to blood disorders, metabolic functions, infectious diseases, and cancer, among others. The company also provides scientific solutions for laboratory customers such as universities, biotechnology and pharmaceutical companies, government, hospitals, and commercial laboratories. It operates across the US, Europe, Canada, and Asia with clinical and research systems operating in laboratories around the world. Beckman is headquartered in Brea, California, the US.
Headquarters
United States of America
Address
250 South Kraemer Boulevard, Brea, California, 92821
Website
www.beckmancoulter.com
Telephone
1 714 9935321
Industry
Medical Equipment
Beckman Coulter Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pre- and Post- Analytical Automation Solutions: | Airfuge |
| Sample Processing Systems | SPINCHRON |
| Total Laboratory Automation Systems | Allegra |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | New Product Approvals | In July, the company received FDA approval for DxC 500 AU Chemistry Analyzer for expanding its portfolio with proven six sigma performance. |
| 2023 | New Products/Services | In May, the company introduced a new advanced immunoassay analyser called DxI 9000 Access. |
| 2023 | Contracts/Agreements | In July, the company came into partnership with Fujirebio Partner to bolster access for patient-friendly, blood-based alzheimer’s disease test. |
Competitor Comparison
| Key Parameters | Beckman Coulter Inc | F. Hoffmann-La Roche Ltd | Thermo Fisher Scientific Inc | Siemens Healthineers AG | Becton Dickinson and Co |
|---|---|---|---|---|---|
| Headquarters | United States of America | Switzerland | United States of America | Germany | United States of America |
| City | Brea | Basel | Waltham | Forchheim | Franklin Lakes |
| State/Province | California | - | Massachusetts | - | New Jersey |
| No. of Employees | - | 103,605 | 122,000 | 71,400 | 73,000 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Ross Bell | Chief Financial Officer; Senior Vice President | Senior Management | - | - |
| Zivjena Vucetic, M.D., Ph.D. | Chief Medical Officer; Senior Vice President | Senior Management | 2022 | - |
| Timea Zsiray | Vice President - Global Marketing | Senior Management | - | - |
| Peter Soltani, Ph.D. | Senior Vice President; General Manager - Hematology, Urinalysis & WITS business unit | Senior Management | - | - |
| Kathleen Orland | General Manager - Clinical Chemistry and Immunoassay; Senior Vice President | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer